CIBC World Markets’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $140M | Buy |
+130,677
| New | +$125M | 0.68% | 27 |
|
|
2025
Q2 | $77.8M | Buy |
99,786
+3,882
| +4% | +$3.02M | 0.49% | 29 |
|
|
2025
Q1 | $79.2M | Sell |
95,904
-29,303
| -23% | -$24.4M | 0.62% | 28 |
|
|
2024
Q4 | $96.7M | Buy |
125,207
+17,022
| +16% | +$14.1M | 0.57% | 31 |
|
|
2024
Q3 | $95.8M | Buy |
108,185
+4,721
| +5% | +$4.24M | 0.69% | 28 |
|
|
2024
Q2 | $93.7M | Sell |
103,464
-15,863
| -13% | -$12.7M | 0.61% | 24 |
|
|
2024
Q1 | $92.8M | Buy |
119,327
+16,421
| +16% | +$11.7M | 0.61% | 25 |
|
|
2023
Q4 | $60M | Buy |
102,906
+58,894
| +134% | +$34.4M | 0.33% | 48 |
|
|
2023
Q3 | $23.6M | Sell |
44,012
-48,326
| -52% | -$24.9M | 0.23% | 75 |
|
|
2023
Q2 | $43.3M | Buy |
92,338
+52,457
| +132% | +$22M | 0.35% | 48 |
|
|
2023
Q1 | $13.7M | Sell |
39,881
-202,837
| -84% | -$68.4M | 0.22% | 88 |
|
|
2022
Q4 | $88.8M | Buy |
242,718
+230,751
| +1,928% | +$81.8M | 0.6% | 23 |
|
|
2022
Q3 | $3.87M | Sell |
11,967
-43,087
| -78% | -$13.7M | 0.05% | 176 |
|
|
2022
Q2 | $17.9M | Sell |
55,054
-108,286
| -66% | -$32.5M | 0.17% | 79 |
|
|
2022
Q1 | $46.8M | Buy |
163,340
+13,601
| +9% | +$3.5M | 0.37% | 54 |
|
|
2021
Q4 | $41.4M | Sell |
149,739
-29,412
| -16% | -$7.46M | 0.22% | 70 |
|
|
2021
Q3 | $41.4M | Buy |
179,151
+98,737
| +123% | +$24.4M | 0.28% | 67 |
|
|
2021
Q2 | $18.5M | Sell |
80,414
-5,322
| -6% | -$1.07M | 0.13% | 106 |
|
|
2021
Q1 | $16M | Sell |
85,736
-60,560
| -41% | -$11.8M | 0.1% | 149 |
|
|
2020
Q4 | $24.7M | Sell |
146,296
-31,117
| -18% | -$4.65M | 0.12% | 129 |
|
|
2020
Q3 | $26.3M | Buy |
177,413
+94,719
| +115% | +$14.7M | 0.26% | 96 |
|
|
2020
Q2 | $13.6M | Buy |
82,694
+20,857
| +34% | +$3.2M | 0.15% | 139 |
|
|
2020
Q1 | $8.58M | Sell |
61,837
-268,672
| -81% | -$36.9M | 0.11% | 163 |
|
|
2019
Q4 | $43.4M | Sell |
330,509
-19,809
| -6% | -$2.3M | 0.28% | 87 |
|
|
2019
Q3 | $39.2M | Buy |
350,318
+148,767
| +74% | +$16.6M | 0.37% | 70 |
|
|
2019
Q2 | $22.3M | Sell |
201,551
-163,125
| -45% | -$19.2M | 0.17% | 140 |
|
|
2019
Q1 | $47.3M | Buy |
364,676
+58,901
| +19% | +$7.16M | 0.39% | 57 |
|
|
2018
Q4 | $35.4M | Buy |
305,775
+41,475
| +16% | +$4.63M | 0.33% | 82 |
|
|
2018
Q3 | $28.4M | Buy |
264,300
+52,022
| +25% | +$5.2M | 0.24% | 105 |
|
|
2018
Q2 | $18.1M | Buy |
212,278
+33,560
| +19% | +$2.76M | 0.16% | 160 |
|
|
2018
Q1 | $13.8M | Sell |
178,718
-212,889
| -54% | -$17.1M | 0.15% | 143 |
|
|
2017
Q4 | $33.1M | Buy |
391,607
+224,198
| +134% | +$19.1M | 0.24% | 90 |
|
|
2017
Q3 | $14.3M | Sell |
167,409
-299,950
| -64% | -$24.6M | 0.14% | 143 |
|
|
2017
Q2 | $38.5M | Buy |
467,359
+365,967
| +361% | +$29.9M | 0.41% | 58 |
|
|
2017
Q1 | $8.53M | Buy |
101,392
+34,723
| +52% | +$2.78M | 0.07% | 197 |
|
|
2016
Q4 | $4.9M | Buy |
+66,669
| New | +$4.97M | 0.05% | 216 |
|
Other funds holding LLY
CIBC World Markets's LLY Position: Q4 2025 in Review
CIBC World Markets opened a new position in Eli Lilly (LLY) in Q4 2025: 130,677 shares worth $140M. The stake represents 0.68% of the portfolio and ranks #27 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in LLY as recently as Q2 2025.
CIBC World Markets first reported a position in LLY in Q4 2016 and has held it in 36 quarters since. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.
- CIBC World Markets held 130,677 shares of Eli Lilly worth $140M as of Q4 2025.
- Eli Lilly was a new CIBC World Markets position in Q4 2025.
- Eli Lilly made up 0.68% of CIBC World Markets's portfolio in Q4 2025, its #27 holding.
- CIBC World Markets first reported a position in Eli Lilly in Q4 2016 and has held it in 36 quarters since.
- 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.
Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.